NSG552 Exam 3 questions with verified answers
acamprosate Ans✓✓✓ NMDA receptor antagonist that is renally cleared, suitable
for AUD patients with hepatic dysfunction.
alcohol intoxication Ans✓✓✓ Signs vary with blood levels, from decreased
reaction time, muscle incoordination, ataxia, dysarthria, to respiratory failure and
coma.
alcohol withdrawal seizures Ans✓✓✓ Treatment includes diazepam IV or
lorazepam IV/IM, thiamine IV/IM, and addressing electrolyte imbalances.
antisocial Ans✓✓✓ Cluster B personality disorder that begins as a conduct
disorder in childhood.
atomoxetine Ans✓✓✓ Second line treatment, non-stimulant, used in patients
with history of SUD or when family prefers non-stimulant.
atypical antipsychotics Ans✓✓✓ Treatment for agitation in patients with
dementia.
behavioral therapy Ans✓✓✓ Modality for the management of IDD deficits.
benzodiazepines Ans✓✓✓ Class of drugs to avoid for acute alcohol intoxication.
buprenorphine Ans✓✓✓ Mu receptor partial agonist for opioid withdrawal.
, buprenorphine Ans✓✓✓ Taking this medication too soon after last opioid use
increases the chances of intense withdrawal that comes on very quickly
(precipitated withdrawal).
buprenorphine+naloxone Ans✓✓✓ Treatment for opioid use disorder with
comorbid pain.
bupropion Ans✓✓✓ Most appropriate medication for a female with depression
and hypoarousal.
bupropion, TCA Ans✓✓✓ Non-stimulant ADHD treatment most appropriate in a
patient with co-occurring depression, and class considered a "reasonable choice"
in a patient with co-occurring depression AND anxiety.
buproprion Ans✓✓✓ Patients on what medication for smoking cessation
treatment should be observed for neuropsychiatric symptoms including changes
in behavior, hostility, agitation, depressed mood, and suicide-related events,
including ideation, behavior, and attempted suicide.
BZD Ans✓✓✓ Class of medications strongly discouraged in treating BPD, due to
risks of worsening impulsivity and suicidality.
BZD Ans✓✓✓ Used only for short term and acute episodes of aggression,
agitation, and psychosis in patients with dementia.
cardiovascular Ans✓✓✓ Prior to starting a stimulant, patient history, family
history, and exam should be conducted with what focus?
acamprosate Ans✓✓✓ NMDA receptor antagonist that is renally cleared, suitable
for AUD patients with hepatic dysfunction.
alcohol intoxication Ans✓✓✓ Signs vary with blood levels, from decreased
reaction time, muscle incoordination, ataxia, dysarthria, to respiratory failure and
coma.
alcohol withdrawal seizures Ans✓✓✓ Treatment includes diazepam IV or
lorazepam IV/IM, thiamine IV/IM, and addressing electrolyte imbalances.
antisocial Ans✓✓✓ Cluster B personality disorder that begins as a conduct
disorder in childhood.
atomoxetine Ans✓✓✓ Second line treatment, non-stimulant, used in patients
with history of SUD or when family prefers non-stimulant.
atypical antipsychotics Ans✓✓✓ Treatment for agitation in patients with
dementia.
behavioral therapy Ans✓✓✓ Modality for the management of IDD deficits.
benzodiazepines Ans✓✓✓ Class of drugs to avoid for acute alcohol intoxication.
buprenorphine Ans✓✓✓ Mu receptor partial agonist for opioid withdrawal.
, buprenorphine Ans✓✓✓ Taking this medication too soon after last opioid use
increases the chances of intense withdrawal that comes on very quickly
(precipitated withdrawal).
buprenorphine+naloxone Ans✓✓✓ Treatment for opioid use disorder with
comorbid pain.
bupropion Ans✓✓✓ Most appropriate medication for a female with depression
and hypoarousal.
bupropion, TCA Ans✓✓✓ Non-stimulant ADHD treatment most appropriate in a
patient with co-occurring depression, and class considered a "reasonable choice"
in a patient with co-occurring depression AND anxiety.
buproprion Ans✓✓✓ Patients on what medication for smoking cessation
treatment should be observed for neuropsychiatric symptoms including changes
in behavior, hostility, agitation, depressed mood, and suicide-related events,
including ideation, behavior, and attempted suicide.
BZD Ans✓✓✓ Class of medications strongly discouraged in treating BPD, due to
risks of worsening impulsivity and suicidality.
BZD Ans✓✓✓ Used only for short term and acute episodes of aggression,
agitation, and psychosis in patients with dementia.
cardiovascular Ans✓✓✓ Prior to starting a stimulant, patient history, family
history, and exam should be conducted with what focus?
